Under the terms of the agreement, ViaNautis will receive an initial upfront payment from Lilly, with the short-term potential for additional payments including research-based milestones. Further ...
Hosted on MSN25m
Is Viking Therapeutics a Buy on the Dip?The biotech company presented solid data for a candidate that could eventually rival blockbuster weight loss drugs from big ...
Sahpra warns of falsified diabetes treatments Ozempic and Mounjaro sold online for weight loss, posing health risks.
Barchart on MSN2h
Eli Lilly Stock: Is Wall Street Bullish or Bearish?Headquartered in Indianapolis, Indiana, Eli Lilly and Company (LLY) is a leading biopharmaceutical firm with a market cap of ...
As Chief Commercial Officer at Zoetis, Jamie Brannan will lead an evolved commercial organizational structure that will ...
SAN ANTONIO — Oral semaglutide 25 mg appears to be just as effective in promoting weight loss and other beneficial outcomes ...
With Eisai and Biogen’s Leqembi and Eli Lilly’s Kisunla launching onto the market, the 2024 Clinical Trials of Alzheimer’s ...
Tesla remains a significant holding for The Future Fund despite position reductions, according to Managing Partner Gary Black ...
The drugs whose labels were updated include Novo Nordisk’s Ozempic and Wegovy and Eli Lilly’s Mounjaro. The agency said, ...
We recently published a list of 10 Best Stocks to Buy According to Billionaire Ken Fisher. In this article, we are going to ...
Conditions are getting a bit more challenging for the drugmaker.
In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback